참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ciprofloxacin | HCID 2764 | — |
| 반응물 | Sodium Chloride | HCID 5234 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Ciprofloxacin Hydrochloride Anhydrous | HCID 62999 | — |
반응 단계
The bandage was placed in a capped vial containing 1 ml of 0.9% NaCl in distilled water at 25° C. After 1 hr of gentle stirring, the aqueous phase was collected and the bandage was placed in a fresh 1 ml portion of 0.9% NaCl. This process was repeated for a total of 24 hour periods. The following procedure for HPLC analysis of ciprofloxacin was essentially that of Darouiche, R. et al, [J. Inf Dis 162, 1124-1125 (1990)]. The conditions were a Whatman Partisil 50D5-3 (C8) column with a mobile phase of 25 ml 0.5M Bu4NHPO4 made up to 2.5 L with distilled water, pH adjusted to 2.34 with 85% H3PO4, which was added to 278 ml HPLC grade acetonitrile, filtered through a 0.2 μ membrane and degassed. The flow rate was 1.5 ml/min at 25° C. with a 500 μl injection loop with detection at 280 nm. Under these conditions ciprofloxacin eluted as a single peak at 9 min. HPLC analysis of the 24 aqueous fractions gave the elution profile shown in Table 2. The data in Table 2 showed that 74% of the initial charge of ciprofloxacin was released in the first 4 hrs. and the release of ciprofloxacin in the subsequent 5 to 24 hrs was remarkably constant. This was thought to be due to the gradual release of ciprofloxacin trapped in the cryogel matrix.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05288503 |
|---|
| 출처 데이터셋 | uspto-grants-1994_02 |
|---|
| ORD ID | ord-c3556700e9e94c06b5a4830e83f31804 |
|---|
| 출처 메모 | uspto-grants-1994_02 |
|---|